Exact Sciences Corp
(STU:EXK)
€
50.94
-14.13 (-21.72%)
Market Cap: 9.26 Bil
Enterprise Value: 10.85 Bil
PE Ratio: 0
PB Ratio: 3.15
GF Score: 77/100 Exact Sciences Corp at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 08:20PM GMT
Release Date Price:
€85.38
(+0.86%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Good afternoon, everyone. Thanks for joining us. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Kevin Conroy, the Chairman and CEO of Exact Sciences. Kevin, thanks for being here.
Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO
Matt, thanks for having me. Thanks to Goldman Sachs, and thank all of you for attending.
Questions & Answers
Matthew Carlisle Sykes;Kevin T.
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe if you could just kind of set the stage for us a little bit and give us an overview of the state of the business post your first quarter results. I know you've got an Investor Day coming up, but just sort of what are you seeing, the trends you saw in Q1? How are you seeing the year play out? What are some of the highlights that you want to go over?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot